Intramuscular triamcinolone acetonide in chronic severe asthma.

Seventeen subjects with chronic severe asthma completed a 48 week prospective, double blind study with crossover of treatment at 24 weeks, in which triamcinolone acetonide 80 mg intramuscularly every four weeks was compared with oral prednisolone 10 mg daily. Spirometry, twice daily measurements of peak expiratory flow rate, and self assessment of asthma symptom scores showed significant improvement during triamcinolone treatment; less extra prednisolone was required and there was significant weight loss. Two patients withdrew, one because of dissatisfaction with prednisolone and one because of side effects while taking triamcinolone. Three were withdrawn, one with proximal muscle weakness and two because of intercurrent illness. Adrenal suppression, bruising, and hirsuitism were worse with triamcinolone, other side effects being comparable. On completion of the study 16 of the 17 patients opted to continue taking triamcinolone acetonide. This treatment is an important addition to the therapeutic options available for chronic severe asthma.

[1]  C. Skinner.  Comparison of oral prednisolone and intramuscular depot triamcinolone in patients with severe chronic asthma. , 1984, Thorax.

[2]  G. Crompton,et al.  Comparison of oral prednisolone and intramuscular depot triamcinolone in patients with severe chronic asthma. , 1984, Thorax.

[3]  R. Crystal,et al.  Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis. , 2015, The American review of respiratory disease.

[4]  G. Crompton,et al.  Corticosteroid resistance in chronic asthma , 1981, British medical journal.

[5]  W. Droszcz,et al.  Factors influencing adrenocortical suppression during long-term triamcinolone acetonide therapy in asthma. , 1980, Annals of allergy.

[6]  G. J. Blackwell,et al.  Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation , 1979, Nature.

[7]  M. Peake,et al.  Triamcinolone in corticosteroid-resistant asthma. , 1979, British journal of diseases of the chest.

[8]  H. Arnold.  SAFER LONG‐TERM STEROID THERAPY WITH INJECTED TRIAMCINOLONE ACETONIDE , 1978, International journal of dermatology.

[9]  R. Mellinger,et al.  Long-term intramuscular administration of triamcinolone acetonide. , 1977, Archives of dermatology.

[10]  T. E. Carson.  Long-Term Intramuscular Administration of Triamcinolone Acetonide-Reply , 1976 .

[11]  D. Pearlman.  Long-term intramuscular administration of triamcinolone acetonide. , 1976, Archives of dermatology.

[12]  T. Daane,et al.  Long-term intramuscular administration of triamcinolone acetonide. Effect on the hypothalamic-pituitary-adrenal axis. , 1975, Archives of dermatology.

[13]  Harris Dm.  Some properties of beclomethasone dipropionate and related steroids in man. , 1975 .

[14]  D. Harris.  Some properties of beclomethasone dipropionate and related steroids in man. , 1975, Postgraduate medical journal.

[15]  R. Mellinger,et al.  Parenteral long-acting corticosteroids: effect on hypothalamic-pituitary-adrenal function. , 1973, Annals of allergy.

[16]  N. Sakauchi,et al.  Studies of plasma levels and urinary excretion after intramuscular injection of triamcinolone acetonide. , 1971, Metabolism: clinical and experimental.

[17]  J. Nash,et al.  Corticosteroid therapy in chronic asthma. , 1968, The Practitioner.

[18]  I. Grant,et al.  Corticosteroids in treatment of chronic asthma. , 1966, British medical journal.